Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells

M Luo, H Fan, T Nagy, H Wei, C Wang, S Liu… - Cancer research, 2009 - AACR
M Luo, H Fan, T Nagy, H Wei, C Wang, S Liu, MS Wicha, JL Guan
Cancer research, 2009AACR
Focal adhesion kinase (FAK) has been implicated in the development of cancers, including
those of the breast. Nevertheless, the molecular and cellular mechanisms by which FAK
promotes mammary tumorigenesis in vivo are not well understood. Here, we show that
targeted deletion of FAK in mouse mammary epithelium significantly suppresses mammary
tumorigenesis in a well-characterized breast cancer model. Ablation of FAK leads to the
depletion of a subset of bipotent cells in the tumor that express both luminal marker keratin …
Abstract
Focal adhesion kinase (FAK) has been implicated in the development of cancers, including those of the breast. Nevertheless, the molecular and cellular mechanisms by which FAK promotes mammary tumorigenesis in vivo are not well understood. Here, we show that targeted deletion of FAK in mouse mammary epithelium significantly suppresses mammary tumorigenesis in a well-characterized breast cancer model. Ablation of FAK leads to the depletion of a subset of bipotent cells in the tumor that express both luminal marker keratin 8/18 and basal marker keratin 5. Using mammary stem/progenitor markers, including aldehyde dehydrogenase, CD24, CD29, and CD61, we further revealed that ablation of FAK reduced the pool of cancer stem/progenitor cells in primary tumors of FAK-targeted mice and impaired their self-renewal and migration in vitro. Finally, through transplantation in NOD-SCID mice, we found that cancer stem/progenitor cells isolated from FAK-targeted mice have compromised tumorigenicity and impaired maintenance in vivo. Together, these results show a novel function of FAK in maintaining the mammary cancer stem/progenitor cell population and provide a novel mechanism by which FAK may promote breast cancer development and progression. [Cancer Res 2009;69(2):466–74]
AACR